首页 > 最新文献

Tropical Diseases, Travel Medicine and Vaccines最新文献

英文 中文
Understanding international travelers' health risk perceptions, preferences, and decisions: a segmentation analysis. 了解国际旅行者的健康风险认知、偏好和决策:一种细分分析。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2025-06-15 DOI: 10.1186/s40794-025-00252-5
Elizabeth Pellecer Rivera, Sandra De Urioste-Stone, Laura N Rickard, Anup K C, Julio Rodríguez Stimson, Andrea Caprara, Lorena N Estrada

Background: This study assesses international travelers' risk perceptions and travel decisions related to three recent emerging diseases. Travelers can facilitate the spread of emerging infectious diseases and their decision-making on where to travel is influenced by outbreaks. These feedback loops can potentially impact the tourism economy. Often, travelers' judgment and actions towards a risk are based on their perceptions.

Method: We conducted two surveys, using constructs from the Health Belief Model, with 747 individuals who had recently traveled to selected Latin American countries, and who had heard about Zika virus, chikungunya, and/or COVID-19. Using segmentation analysis, the respondents were grouped based on their risk perception level (i.e., low, medium and high), and we tested the differences between groups for different constructs of the model.

Results: We found a significant difference between the risk perception groups for most of the sociodemographic factors, as well as for the purpose of the trip, regarding travel preferences. Personal experience with a disease and perceived efficacy towards diverse protective measures also differed between groups. Higher risk perception was related to reporting more changes in past travel plans, and higher likelihood of future travel avoidance if facing different risk scenarios in a tourism destination.

Conclusions: Including the concepts of risk perception, sociodemographic factors, previous experience, and efficacy can help better explain the individual behavior of international travelers. These findings can inform tailored and more effective mitigation and management strategies to promote safe travel and prevent disease spread in the event of a future outbreak.

背景:本研究评估了国际旅行者对最近出现的三种疾病的风险认知和旅行决策。旅行者可以促进新出现的传染病的传播,他们决定去哪里旅行受到疫情的影响。这些反馈循环可能会对旅游经济产生潜在影响。通常,旅行者对风险的判断和行动是基于他们的感知。方法:我们使用健康信念模型的结构进行了两项调查,调查对象是747名最近去过选定的拉丁美洲国家,并且听说过寨卡病毒、基孔肯雅热和/或COVID-19的人。使用分割分析,根据受访者的风险感知水平(即低、中、高)对其进行分组,并对不同模型构建的组间差异进行检验。结果:我们发现,在大多数社会人口因素和旅行目的方面,风险感知组之间存在显著差异。不同群体之间的个人疾病经历和对各种保护措施的感知效果也有所不同。较高的风险感知与报告过去旅行计划的更多变化有关,并且如果在旅游目的地面临不同的风险情景,则更有可能避免未来的旅行。结论:纳入风险感知、社会人口学因素、既往经验和有效性的概念有助于更好地解释国际旅行者的个体行为。这些研究结果可为有针对性和更有效的缓解和管理战略提供信息,以促进安全旅行,并在未来爆发疫情时预防疾病传播。
{"title":"Understanding international travelers' health risk perceptions, preferences, and decisions: a segmentation analysis.","authors":"Elizabeth Pellecer Rivera, Sandra De Urioste-Stone, Laura N Rickard, Anup K C, Julio Rodríguez Stimson, Andrea Caprara, Lorena N Estrada","doi":"10.1186/s40794-025-00252-5","DOIUrl":"10.1186/s40794-025-00252-5","url":null,"abstract":"<p><strong>Background: </strong>This study assesses international travelers' risk perceptions and travel decisions related to three recent emerging diseases. Travelers can facilitate the spread of emerging infectious diseases and their decision-making on where to travel is influenced by outbreaks. These feedback loops can potentially impact the tourism economy. Often, travelers' judgment and actions towards a risk are based on their perceptions.</p><p><strong>Method: </strong>We conducted two surveys, using constructs from the Health Belief Model, with 747 individuals who had recently traveled to selected Latin American countries, and who had heard about Zika virus, chikungunya, and/or COVID-19. Using segmentation analysis, the respondents were grouped based on their risk perception level (i.e., low, medium and high), and we tested the differences between groups for different constructs of the model.</p><p><strong>Results: </strong>We found a significant difference between the risk perception groups for most of the sociodemographic factors, as well as for the purpose of the trip, regarding travel preferences. Personal experience with a disease and perceived efficacy towards diverse protective measures also differed between groups. Higher risk perception was related to reporting more changes in past travel plans, and higher likelihood of future travel avoidance if facing different risk scenarios in a tourism destination.</p><p><strong>Conclusions: </strong>Including the concepts of risk perception, sociodemographic factors, previous experience, and efficacy can help better explain the individual behavior of international travelers. These findings can inform tailored and more effective mitigation and management strategies to promote safe travel and prevent disease spread in the event of a future outbreak.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"20"},"PeriodicalIF":2.4,"publicationDate":"2025-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12167583/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144295013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing the burden of leptospirosis in Africa. 解决非洲钩端螺旋体病的负担。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2025-06-07 DOI: 10.1186/s40794-025-00250-7
Colin Musara, Frank Kapungu

Leptospirosis is a zoonosis of global distribution. The U.S. Centers for Disease Control and Prevention has designated leptospirosis a nationally notifiable disease. There is need to raise awareness of the burden of leptospirosis among health care givers and policy makers in Africa. The aim of this review was to highlight the current situation of leptospirosis in Africa and suggest a One Health approach of addressing its status as a leading zoonosis. In tropical regions, the nonspecific symptoms of fever, myalgia and arthralgia result in misdiagnosis of leptospirosis with malaria, yellow fever, typhoid fever, dengue fever, brucellosis, rickettsiosis, and babesiosis. Urinalysis presents an inexpensive diagnostic aid for leptospirosis. Humans with leptospirosis exhibit proteinuria, glucosuria, pyuria, haematuria and granular casts resulting from acute kidney injury. Therapeutic guidelines for empirical treatment of febrile patients should be considered. Febrile patients who test negative for malaria and yellow fever can benefit from doxycycline, which also treats brucellosis, rickettsiosis and typhoid fever. Control of leptospirosis should also address Leptospira infection in domestic animal reservoirs through vaccination of cattle, sheep, goats, pigs and dogs in endemic areas. Treatment of sick animals with streptomycin eliminates the carrier status, curbing leptospiruria and spread of infection. Rodents are important in transmission of Leptospira to humans in urban slums and rural settings therefore rodent control strategies help in reducing transmission of leptospirosis. Indirect transmission of Leptospira occurs through contact with water, vegetation, or soil contaminated with infected urine. Drinking water should be drawn from protected sources or chlorinated before household use.

钩端螺旋体病是一种全球分布的人畜共患病。美国疾病控制和预防中心已将钩端螺旋体病指定为全国法定疾病。有必要提高非洲卫生保健提供者和决策者对钩端螺旋体病负担的认识。本综述的目的是强调非洲钩端螺旋体病的现状,并建议采用“同一个健康”方法来解决其作为主要人畜共患病的地位。在热带地区,发热、肌痛和关节痛等非特异性症状导致钩端螺旋体病与疟疾、黄热病、伤寒、登革热、布鲁氏菌病、李克次体病和巴贝斯虫病的误诊。尿液分析是钩端螺旋体病的廉价诊断手段。患有钩端螺旋体病的人表现为蛋白尿、糖尿、脓尿、血尿和急性肾损伤引起的粒状铸型。应考虑发热病人经验性治疗的治疗指南。疟疾和黄热病检测呈阴性的发热患者可受益于强力霉素,强力霉素还可治疗布鲁氏菌病、立克次体病和伤寒。控制钩端螺旋体病还应通过对流行地区的牛、绵羊、山羊、猪和狗接种疫苗来解决家畜宿主中的钩端螺旋体感染问题。用链霉素治疗患病动物可消除带菌者状态,抑制钩端螺旋体和感染的传播。在城市贫民窟和农村环境中,啮齿动物是钩端螺旋体向人类传播的重要因素,因此啮齿动物控制战略有助于减少钩端螺旋体病的传播。钩端螺旋体通过接触被感染尿液污染的水、植被或土壤间接传播。饮用水应取自受保护的水源,或在家庭使用前进行氯化处理。
{"title":"Addressing the burden of leptospirosis in Africa.","authors":"Colin Musara, Frank Kapungu","doi":"10.1186/s40794-025-00250-7","DOIUrl":"10.1186/s40794-025-00250-7","url":null,"abstract":"<p><p>Leptospirosis is a zoonosis of global distribution. The U.S. Centers for Disease Control and Prevention has designated leptospirosis a nationally notifiable disease. There is need to raise awareness of the burden of leptospirosis among health care givers and policy makers in Africa. The aim of this review was to highlight the current situation of leptospirosis in Africa and suggest a One Health approach of addressing its status as a leading zoonosis. In tropical regions, the nonspecific symptoms of fever, myalgia and arthralgia result in misdiagnosis of leptospirosis with malaria, yellow fever, typhoid fever, dengue fever, brucellosis, rickettsiosis, and babesiosis. Urinalysis presents an inexpensive diagnostic aid for leptospirosis. Humans with leptospirosis exhibit proteinuria, glucosuria, pyuria, haematuria and granular casts resulting from acute kidney injury. Therapeutic guidelines for empirical treatment of febrile patients should be considered. Febrile patients who test negative for malaria and yellow fever can benefit from doxycycline, which also treats brucellosis, rickettsiosis and typhoid fever. Control of leptospirosis should also address Leptospira infection in domestic animal reservoirs through vaccination of cattle, sheep, goats, pigs and dogs in endemic areas. Treatment of sick animals with streptomycin eliminates the carrier status, curbing leptospiruria and spread of infection. Rodents are important in transmission of Leptospira to humans in urban slums and rural settings therefore rodent control strategies help in reducing transmission of leptospirosis. Indirect transmission of Leptospira occurs through contact with water, vegetation, or soil contaminated with infected urine. Drinking water should be drawn from protected sources or chlorinated before household use.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"16"},"PeriodicalIF":2.4,"publicationDate":"2025-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12144825/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144249776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasmodium falciparum malaria runs a more severe course in splenectomized patients at comparable levels of parasitemia: a retrospective matched case-control study. 恶性疟原虫疟疾在同等水平寄生虫血症的脾切除患者中运行更严重的过程:回顾性匹配病例对照研究。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2025-06-03 DOI: 10.1186/s40794-025-00255-2
Maria I Otto, Klaske J Vliegenthart-Jongbloed, Jaap J van Hellemond, Perry Jj van Genderen

Background: The spleen plays a vital role in combating Plasmodium infections, particularly during the erythrocytic stage of the infection. Asplenia may notably affect disease progression and parasite clearance dynamics. More insight is needed as to whether asplenic malaria patients - beyond considerations of parasite load - also face a higher burden of disease caused by malaria-specific manifestations of organ dysfunction and/or metabolic deterioration.

Methods: A case-control study was conducted comparing splenectomized malaria patients with non-splenectomized individuals at comparable parasitemia levels. Control subjects were sourced from the Rotterdam Malaria Cohort Study. Due to the cohort's limited asplenic cases, a systematic literature review identified 13 additional asplenic malaria cases. Each case was matched for age and P. falciparum parasitemia level with 3 control subjects resulting in 45 case-control paired observations.

Findings: The study included a total of 60 P.falciparum malaria patients, comprising 15 splenectomized patients (cases) and 45 non-splenectomized patients (controls). Eleven of 15 cases (73%) met WHO criteria for severe disease, in contrast to 21 of 45 (47%) matched controls. Cases had significantly longer median duration of hospitalizations (10 versus 5.5 days) and higher rates of hemodynamic instability. Splenectomized malaria patients had a significantly 3-fold higher odds of experiencing WHO-defined severe disease malaria (OR 3.14 (95% CI 1.30-7.60)) than matched controls.

Conclusion: The findings of this case-control study suggest that - at comparable levels of parasitemia - P. falciparum malaria infections in asplenic individuals may run a more severe course as compared with individuals who have not undergone splenectomy.

背景:脾脏在对抗疟原虫感染中起着至关重要的作用,特别是在感染的红细胞阶段。脾虚可能显著影响疾病进展和寄生虫清除动力学。需要更深入地了解,除了寄生虫负荷的考虑之外,无脾疟疾患者是否也面临由疟疾特有的器官功能障碍和/或代谢恶化的表现引起的更高的疾病负担。方法:采用病例对照研究的方法,对疟疾脾切除患者和未脾切除患者进行比较。对照对象来自鹿特丹疟疾队列研究。由于该队列的无脾病例有限,系统的文献回顾确定了另外13例无脾疟疾病例。每个病例的年龄和恶性疟原虫水平与3名对照受试者相匹配,产生45例病例-对照配对观察。结果:本研究共纳入60例恶性疟患者,其中脾切除术患者(病例)15例,未脾切除术患者(对照组)45例。15例中有11例(73%)符合世卫组织的严重疾病标准,而45例中有21例(47%)符合对照。病例的中位住院时间明显更长(10天对5.5天),血流动力学不稳定的发生率更高。脾切除疟疾患者经历世卫组织定义的重症疟疾的几率(OR 3.14 (95% CI 1.30-7.60))比匹配对照组显著高出3倍。结论:这项病例对照研究的结果表明,在寄生虫血症水平相当的情况下,无脾个体的恶性疟原虫疟疾感染可能比未接受脾切除术的个体更严重。
{"title":"Plasmodium falciparum malaria runs a more severe course in splenectomized patients at comparable levels of parasitemia: a retrospective matched case-control study.","authors":"Maria I Otto, Klaske J Vliegenthart-Jongbloed, Jaap J van Hellemond, Perry Jj van Genderen","doi":"10.1186/s40794-025-00255-2","DOIUrl":"10.1186/s40794-025-00255-2","url":null,"abstract":"<p><strong>Background: </strong>The spleen plays a vital role in combating Plasmodium infections, particularly during the erythrocytic stage of the infection. Asplenia may notably affect disease progression and parasite clearance dynamics. More insight is needed as to whether asplenic malaria patients - beyond considerations of parasite load - also face a higher burden of disease caused by malaria-specific manifestations of organ dysfunction and/or metabolic deterioration.</p><p><strong>Methods: </strong>A case-control study was conducted comparing splenectomized malaria patients with non-splenectomized individuals at comparable parasitemia levels. Control subjects were sourced from the Rotterdam Malaria Cohort Study. Due to the cohort's limited asplenic cases, a systematic literature review identified 13 additional asplenic malaria cases. Each case was matched for age and P. falciparum parasitemia level with 3 control subjects resulting in 45 case-control paired observations.</p><p><strong>Findings: </strong>The study included a total of 60 P.falciparum malaria patients, comprising 15 splenectomized patients (cases) and 45 non-splenectomized patients (controls). Eleven of 15 cases (73%) met WHO criteria for severe disease, in contrast to 21 of 45 (47%) matched controls. Cases had significantly longer median duration of hospitalizations (10 versus 5.5 days) and higher rates of hemodynamic instability. Splenectomized malaria patients had a significantly 3-fold higher odds of experiencing WHO-defined severe disease malaria (OR 3.14 (95% CI 1.30-7.60)) than matched controls.</p><p><strong>Conclusion: </strong>The findings of this case-control study suggest that - at comparable levels of parasitemia - P. falciparum malaria infections in asplenic individuals may run a more severe course as compared with individuals who have not undergone splenectomy.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"18"},"PeriodicalIF":2.4,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12131750/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144209627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Work-related connectivity between Boston Logan international airport and urban communities with high social vulnerability during the COVID-19 pandemic. 2019冠状病毒病大流行期间,波士顿洛根国际机场与社会脆弱性高的城市社区之间的工作相关连通性。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2025-06-01 DOI: 10.1186/s40794-025-00249-0
Daniel Begemann, Cristina Alonso, Samantha Bates, Edward T Ryan, Allison T Walker, Barry Keppard, Ann Marie Kissel, Flor Amaya, Sowmya R Rao, Tyler S Brown, Amir M Mohareb, Julie H Levison, Regina C LaRocque

Airports may be high-risk sites for the spread of infectious diseases, including novel respiratory pathogens. While many studies have evaluated the higher burden of COVID-19 among essential workers, few studies have specifically analyzed the links between airport workers and surrounding communities during the COVID-19 pandemic. We used GPS-derived mobility data to estimate work- and travel-related visits from approximately 5000 Boston-area census block groups to Logan International Airport between January 2020 and August 2021. We stratified origin census block groups by their census tract-level Social Vulnerability Index and compared temporal trends and work-related airport visits across Social Vulnerability Index quartiles. Work-related visits to Boston Logan International Airport were more likely to originate from socially vulnerable communities (i.e., in the highest Social Vulnerability Index quartile), including cities that experienced disproportionately high rates of COVID-19 infection early during the COVID-19 pandemic (East Boston, Revere and Chelsea, Massachusetts). These differences persisted across the duration of the observation period. Our findings highlight higher social vulnerability and strong work-related mobility connections with an international travel hub as important overlapping risk factors in these urban communities. Protecting airport workers and their home communities from imported infectious diseases merits further attention as a public health priority.

机场可能是传染病(包括新型呼吸道病原体)传播的高风险场所。虽然许多研究评估了COVID-19在基本工作人员中的较高负担,但很少有研究专门分析了COVID-19大流行期间机场工作人员与周围社区之间的联系。我们使用gps衍生的流动性数据来估计2020年1月至2021年8月期间波士顿地区约5000个人口普查街区对洛根国际机场的工作和旅行相关访问。我们根据人口普查区的社会脆弱性指数对原籍人口普查分组进行分层,并比较了社会脆弱性指数四分位数的时间趋势和与工作相关的机场访问量。与波士顿洛根国际机场工作相关的访问更有可能来自社会弱势社区(即社会脆弱性指数最高的四分位数),包括在COVID-19大流行早期经历了不成比例的COVID-19感染率的城市(东波士顿、里维尔和马萨诸塞州的切尔西)。这些差异在整个观察期间持续存在。我们的研究结果强调,在这些城市社区中,较高的社会脆弱性和与国际旅游中心密切的工作相关流动性联系是重要的重叠风险因素。作为一项公共卫生优先事项,保护机场工作人员及其家庭社区免受输入性传染病的侵害值得进一步关注。
{"title":"Work-related connectivity between Boston Logan international airport and urban communities with high social vulnerability during the COVID-19 pandemic.","authors":"Daniel Begemann, Cristina Alonso, Samantha Bates, Edward T Ryan, Allison T Walker, Barry Keppard, Ann Marie Kissel, Flor Amaya, Sowmya R Rao, Tyler S Brown, Amir M Mohareb, Julie H Levison, Regina C LaRocque","doi":"10.1186/s40794-025-00249-0","DOIUrl":"10.1186/s40794-025-00249-0","url":null,"abstract":"<p><p>Airports may be high-risk sites for the spread of infectious diseases, including novel respiratory pathogens. While many studies have evaluated the higher burden of COVID-19 among essential workers, few studies have specifically analyzed the links between airport workers and surrounding communities during the COVID-19 pandemic. We used GPS-derived mobility data to estimate work- and travel-related visits from approximately 5000 Boston-area census block groups to Logan International Airport between January 2020 and August 2021. We stratified origin census block groups by their census tract-level Social Vulnerability Index and compared temporal trends and work-related airport visits across Social Vulnerability Index quartiles. Work-related visits to Boston Logan International Airport were more likely to originate from socially vulnerable communities (i.e., in the highest Social Vulnerability Index quartile), including cities that experienced disproportionately high rates of COVID-19 infection early during the COVID-19 pandemic (East Boston, Revere and Chelsea, Massachusetts). These differences persisted across the duration of the observation period. Our findings highlight higher social vulnerability and strong work-related mobility connections with an international travel hub as important overlapping risk factors in these urban communities. Protecting airport workers and their home communities from imported infectious diseases merits further attention as a public health priority.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"15"},"PeriodicalIF":2.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12126863/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144192289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current update on malaria in pregnancy: a systematic review. 妊娠期疟疾最新情况:系统回顾。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2025-05-22 DOI: 10.1186/s40794-025-00248-1
Awoke Minwuyelet, Delenasaw Yewhalaw, Melkamu Siferih, Getnet Atenafu

Background: Malaria during pregnancy poses significant risks to both the mother and the developing fetus. For pregnant women, the infection can result in severe illness and even death. Parasite sequestration in the placenta can cause maternal anemia and increase the risk of mortality both during and after childbirth. Malaria is also a major contributor to stillbirths and preterm births. Infected placental tissue can impede fetal growth, resulting in low birth weight, which is linked to delayed growth and cognitive development in the child. Furthermore, malaria during pregnancy remains a major contributor to perinatal, neonatal, and infant mortality.

Objectives: To review the epidemiological patterns of malaria in pregnancy and its impact on maternal and neonatal health, and to analyze the availability and effectiveness of drug treatment options.

Methods: Relevant articles published only in English were searched using electronic databases such as PubMed, Web of Science, Scopus, and Pro-Quest. Keywords including "'malaria in pregnancy", "placental malaria", "congenital malaria", "treatment options", and "nutrition intervention and intermittent preventive treatment" were used in combination. Of the total of 4,486 articles identified, 139 articles were ultimately included. Whereas, others were excluded due to duplication, irrelevant abstract, title, and quality assessment.

Results: From 139 included studies, 47 focused on epidemiology of malaria in pregnancy, 58 on its impact and 16 on treatment options and 18 on nutrition intervention and intermittent treatment. Plasmodium falciparum is the leading cause of complications in pregnant women and is primarily found in Africa, while P.vivax is recognized as an emerging global threat, and causing serious consequences. Other species, such as P.knowlesi, P.ovale, and P.malariae are less common. Malaria prevalence in pregnancy can reach 60% in sub-Saharan Africa and 36% globally, with placental malaria affecting up to 28% of cases. The disease causes serious complications such as maternal anemia, premature birth, and low birth weight, severe anemia and increased maternal and infant mortality. Prevention strategies like intermittent preventive treatment (IPTp), insecticide-treated nets (ITNs) and Indoor residual spray (IRS) are essential. Early diagnosis and treatment can reverse adverse effects on placental and congenital function. Artesunate is recommended for severe malaria in all trimesters. Even resistance to chloroquine reported in some areas, it is the drug of choice for uncomplicated P.vivax infections.

Conclusions: Malaria during pregnancy significantly impacts maternal and fetal health, leading to anemia, growth restriction, preterm birth, and neonatal death. Infants born to mothers with malaria are more likely to contract the disease. Further research and improved treatment strategies are

背景:怀孕期间的疟疾对母亲和发育中的胎儿都有重大风险。对于孕妇来说,这种感染会导致严重的疾病甚至死亡。胎盘中寄生虫的隔离会导致母体贫血,并增加分娩期间和分娩后的死亡风险。疟疾也是造成死产和早产的一个主要因素。受感染的胎盘组织可阻碍胎儿生长,导致出生体重过低,这与儿童生长和认知发育迟缓有关。此外,怀孕期间的疟疾仍然是围产期、新生儿和婴儿死亡的一个主要原因。目的:审查妊娠期疟疾的流行病学模式及其对孕产妇和新生儿健康的影响,并分析药物治疗方案的可得性和有效性。方法:使用PubMed、Web of Science、Scopus、Pro-Quest等电子数据库检索相关英文文献。关键词包括“孕期疟疾”、“胎盘疟疾”、“先天性疟疾”、“治疗方案”、“营养干预与间歇预防治疗”。在确定的4486篇文章中,最终纳入了139篇文章。然而,由于重复、不相关的摘要、标题和质量评估,其他文献被排除。结果:139项纳入的研究中,47项关注妊娠期疟疾流行病学,58项关注其影响,16项关注治疗方案,18项关注营养干预和间歇性治疗。恶性疟原虫是孕妇并发症的主要原因,主要在非洲发现,而间日疟原虫被认为是一种新出现的全球威胁,并造成严重后果。其他种类,如诺氏疟原虫、卵形疟原虫和疟疾疟原虫不太常见。妊娠期疟疾流行率在撒哈拉以南非洲可达60%,在全球可达36%,其中胎盘疟疾影响的病例高达28%。该病引起严重并发症,如产妇贫血、早产、低出生体重、严重贫血和母婴死亡率增加。间歇性预防治疗(IPTp)、驱虫蚊帐(ITNs)和室内残留喷雾(IRS)等预防策略至关重要。早期诊断和治疗可逆转对胎盘和先天性功能的不良影响。建议在所有妊娠期使用青蒿琥酯治疗严重疟疾。甚至在一些地区报告了对氯喹的耐药性,它是治疗无并发症间日疟原虫感染的首选药物。结论:妊娠期疟疾显著影响孕产妇和胎儿健康,导致贫血、生长受限、早产和新生儿死亡。患有疟疾的母亲所生的婴儿更有可能感染这种疾病。需要进一步的研究和改进的治疗策略来有效地解决这一问题。
{"title":"Current update on malaria in pregnancy: a systematic review.","authors":"Awoke Minwuyelet, Delenasaw Yewhalaw, Melkamu Siferih, Getnet Atenafu","doi":"10.1186/s40794-025-00248-1","DOIUrl":"10.1186/s40794-025-00248-1","url":null,"abstract":"<p><strong>Background: </strong>Malaria during pregnancy poses significant risks to both the mother and the developing fetus. For pregnant women, the infection can result in severe illness and even death. Parasite sequestration in the placenta can cause maternal anemia and increase the risk of mortality both during and after childbirth. Malaria is also a major contributor to stillbirths and preterm births. Infected placental tissue can impede fetal growth, resulting in low birth weight, which is linked to delayed growth and cognitive development in the child. Furthermore, malaria during pregnancy remains a major contributor to perinatal, neonatal, and infant mortality.</p><p><strong>Objectives: </strong>To review the epidemiological patterns of malaria in pregnancy and its impact on maternal and neonatal health, and to analyze the availability and effectiveness of drug treatment options.</p><p><strong>Methods: </strong>Relevant articles published only in English were searched using electronic databases such as PubMed, Web of Science, Scopus, and Pro-Quest. Keywords including \"'malaria in pregnancy\", \"placental malaria\", \"congenital malaria\", \"treatment options\", and \"nutrition intervention and intermittent preventive treatment\" were used in combination. Of the total of 4,486 articles identified, 139 articles were ultimately included. Whereas, others were excluded due to duplication, irrelevant abstract, title, and quality assessment.</p><p><strong>Results: </strong>From 139 included studies, 47 focused on epidemiology of malaria in pregnancy, 58 on its impact and 16 on treatment options and 18 on nutrition intervention and intermittent treatment. Plasmodium falciparum is the leading cause of complications in pregnant women and is primarily found in Africa, while P.vivax is recognized as an emerging global threat, and causing serious consequences. Other species, such as P.knowlesi, P.ovale, and P.malariae are less common. Malaria prevalence in pregnancy can reach 60% in sub-Saharan Africa and 36% globally, with placental malaria affecting up to 28% of cases. The disease causes serious complications such as maternal anemia, premature birth, and low birth weight, severe anemia and increased maternal and infant mortality. Prevention strategies like intermittent preventive treatment (IPTp), insecticide-treated nets (ITNs) and Indoor residual spray (IRS) are essential. Early diagnosis and treatment can reverse adverse effects on placental and congenital function. Artesunate is recommended for severe malaria in all trimesters. Even resistance to chloroquine reported in some areas, it is the drug of choice for uncomplicated P.vivax infections.</p><p><strong>Conclusions: </strong>Malaria during pregnancy significantly impacts maternal and fetal health, leading to anemia, growth restriction, preterm birth, and neonatal death. Infants born to mothers with malaria are more likely to contract the disease. Further research and improved treatment strategies are","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"14"},"PeriodicalIF":2.4,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12096600/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144120940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of mRNA vaccines in infectious diseases: a new era of immunization. mRNA疫苗在传染病中的作用:免疫的新时代。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2025-05-15 DOI: 10.1186/s40794-025-00246-3
Kesaobaka Batisani

The emergence of messenger RNA (mRNA) vaccines has marked a seminal shift in the field of immunization, heralding an era characterized by unprecedented speed and efficacy in the face of infectious diseases. The global crisis caused by the COVID-19 pandemic catalyzed the rapid development and deployment of two leading mRNA vaccines, Comirnaty and SpikeVax, showcasing not only the technological promise of mRNA, but also its transformative potential in public health strategies. This study seeks to provide an in-depth exploration of the foundational elements of mRNA vaccine technology, elucidate its unique advantages over traditional vaccine platforms, analyze the existing challenges that public health officials face, and envision future applications that extend far beyond current expectations. Through this exploration, we advocate for the integration of mRNA technology into existing public health frameworks to enhance global health security and adaptability in the face of emerging infectious threats.

信使RNA (mRNA)疫苗的出现标志着免疫领域的一个重大转变,预示着一个以前所未有的速度和效力应对传染病为特征的时代的到来。2019冠状病毒病大流行引发的全球危机促进了两种主要mRNA疫苗Comirnaty和SpikeVax的快速开发和部署,不仅展示了mRNA的技术前景,还展示了其在公共卫生战略中的变革潜力。本研究旨在深入探索mRNA疫苗技术的基本要素,阐明其相对于传统疫苗平台的独特优势,分析公共卫生官员面临的现有挑战,并展望远远超出当前预期的未来应用。通过这一探索,我们提倡将mRNA技术整合到现有的公共卫生框架中,以增强面对新出现的传染性威胁的全球卫生安全和适应性。
{"title":"The role of mRNA vaccines in infectious diseases: a new era of immunization.","authors":"Kesaobaka Batisani","doi":"10.1186/s40794-025-00246-3","DOIUrl":"https://doi.org/10.1186/s40794-025-00246-3","url":null,"abstract":"<p><p>The emergence of messenger RNA (mRNA) vaccines has marked a seminal shift in the field of immunization, heralding an era characterized by unprecedented speed and efficacy in the face of infectious diseases. The global crisis caused by the COVID-19 pandemic catalyzed the rapid development and deployment of two leading mRNA vaccines, Comirnaty and SpikeVax, showcasing not only the technological promise of mRNA, but also its transformative potential in public health strategies. This study seeks to provide an in-depth exploration of the foundational elements of mRNA vaccine technology, elucidate its unique advantages over traditional vaccine platforms, analyze the existing challenges that public health officials face, and envision future applications that extend far beyond current expectations. Through this exploration, we advocate for the integration of mRNA technology into existing public health frameworks to enhance global health security and adaptability in the face of emerging infectious threats.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"12"},"PeriodicalIF":2.4,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12079950/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"Are they going to recollect who they need to contact?": understanding sexually transmitted infection transmission risks among older Canadians who winter in the United States. “他们会想起他们需要联系谁吗?”了解在美国过冬的加拿大老年人的性传播感染传播风险。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2025-05-07 DOI: 10.1186/s40794-025-00245-4
Olivia Nieves Echevarria, John Pickering, Valorie A Crooks, Jeremy Snyder, Trudie Milner

Background: Sexually transmitted infections are on the rise in older populations globally, including among older travellers. International retirement migrants are older people who have retired from the workforce and travel abroad seasonally, typically during the winter months in their home countries. The transnational nature of this practice may challenge public health efforts to control the spread of sexually transmitted infection and encourage treatment. This study focuses on Yuma, Arizona, a popular destination for Canadian international retirement migrants who winter in the United States, to examine the sexual health risks associated with their seasonal travel.

Methods: Utilizing a qualitative case study approach, this research involved semi-structured interviews conducted remotely with key informants in Yuma (n = 10) who held various health care and administrative roles. Participants provided insights into sexual health risks based on their extensive interactions with Canadian seasonal migrants and their knowledge of the social dynamics within retirement communities. Interviews were transcribed verbatim, coded using NVivo software, and thematically analyzed to identify risk factors for sexually transmitted infections among Canadian international retirement migrants wintering in Yuma.

Results: Findings revealed three main risks that may contribute to exposure to sexually transmitted infections and potential transmission: social dynamics within tight-knit retirement migrant communities that facilitate unsafe sexual practices (i.e., risky practices); barriers to accessing diagnostic services, such as costs and lack of established local care (i.e., risky care access); and challenges in following standard treatment and public health protocols due to logistical difficulties in ensuring follow-up (i.e., risky treatment decisions). Key informants noted that lifestyle choices, including the use of alcohol and drugs, can exacerbate these risks. Health care access barriers driven by travel health insurance and mobility limitations further complicate the diagnosis and treatment of sexually transmitted infections for Canadian international retirement migrants while abroad.

Conclusions: This study highlights the complex interplay of social behaviours and health care barriers that heighten the risk of sexually transmitted infection transmission among Canadian retirement migrants in the transnational context of Yuma. Extended diagnostic and treatment services, comprehensive sexual health education in pre- and post-travel consultations, as well as inclusive travel health insurance coverage could significantly improve the sexual health outcomes for this population.

背景:性传播感染在全球老年人群中呈上升趋势,包括在老年旅行者中。国际退休移民是指已经退休的老年人,他们季节性地出国旅行,通常是在本国的冬季。这种做法的跨国性质可能对控制性传播感染蔓延和鼓励治疗的公共卫生努力构成挑战。这项研究的重点是亚利桑那州的尤马,一个受加拿大国际退休移民欢迎的目的地,他们在美国过冬,以检查与他们的季节性旅行相关的性健康风险。方法:利用定性案例研究方法,本研究涉及对尤马(n = 10)担任各种卫生保健和行政职务的关键线人进行远程半结构化访谈。参与者根据他们与加拿大季节性移民的广泛互动以及他们对退休社区内社会动态的了解,提供了关于性健康风险的见解。访谈内容逐字转录,使用NVivo软件编码,并进行主题分析,以确定在尤马过冬的加拿大国际退休移民的性传播感染风险因素。结果:研究结果揭示了可能导致性传播感染暴露和潜在传播的三个主要风险:紧密联系的退休移民社区内的社会动态促进了不安全的性行为(即风险行为);获得诊断服务的障碍,例如费用高昂和缺乏既定的当地护理(即获得高风险护理);以及在遵循标准治疗和公共卫生方案方面的挑战,因为在确保后续行动方面存在后勤困难(即有风险的治疗决定)。主要举报人指出,生活方式的选择,包括使用酒精和毒品,可能加剧这些风险。旅行健康保险和行动限制造成的获得保健服务的障碍,使加拿大国际退休移民在国外的性传播感染的诊断和治疗进一步复杂化。结论:本研究强调了社会行为和卫生保健障碍之间复杂的相互作用,增加了加拿大退休移民在尤马的跨国背景下性传播感染传播的风险。扩大诊断和治疗服务、在旅行前后咨询中进行全面的性健康教育,以及提供全面的旅行健康保险,可显著改善这一人群的性健康结果。
{"title":"\"Are they going to recollect who they need to contact?\": understanding sexually transmitted infection transmission risks among older Canadians who winter in the United States.","authors":"Olivia Nieves Echevarria, John Pickering, Valorie A Crooks, Jeremy Snyder, Trudie Milner","doi":"10.1186/s40794-025-00245-4","DOIUrl":"10.1186/s40794-025-00245-4","url":null,"abstract":"<p><strong>Background: </strong>Sexually transmitted infections are on the rise in older populations globally, including among older travellers. International retirement migrants are older people who have retired from the workforce and travel abroad seasonally, typically during the winter months in their home countries. The transnational nature of this practice may challenge public health efforts to control the spread of sexually transmitted infection and encourage treatment. This study focuses on Yuma, Arizona, a popular destination for Canadian international retirement migrants who winter in the United States, to examine the sexual health risks associated with their seasonal travel.</p><p><strong>Methods: </strong>Utilizing a qualitative case study approach, this research involved semi-structured interviews conducted remotely with key informants in Yuma (n = 10) who held various health care and administrative roles. Participants provided insights into sexual health risks based on their extensive interactions with Canadian seasonal migrants and their knowledge of the social dynamics within retirement communities. Interviews were transcribed verbatim, coded using NVivo software, and thematically analyzed to identify risk factors for sexually transmitted infections among Canadian international retirement migrants wintering in Yuma.</p><p><strong>Results: </strong>Findings revealed three main risks that may contribute to exposure to sexually transmitted infections and potential transmission: social dynamics within tight-knit retirement migrant communities that facilitate unsafe sexual practices (i.e., risky practices); barriers to accessing diagnostic services, such as costs and lack of established local care (i.e., risky care access); and challenges in following standard treatment and public health protocols due to logistical difficulties in ensuring follow-up (i.e., risky treatment decisions). Key informants noted that lifestyle choices, including the use of alcohol and drugs, can exacerbate these risks. Health care access barriers driven by travel health insurance and mobility limitations further complicate the diagnosis and treatment of sexually transmitted infections for Canadian international retirement migrants while abroad.</p><p><strong>Conclusions: </strong>This study highlights the complex interplay of social behaviours and health care barriers that heighten the risk of sexually transmitted infection transmission among Canadian retirement migrants in the transnational context of Yuma. Extended diagnostic and treatment services, comprehensive sexual health education in pre- and post-travel consultations, as well as inclusive travel health insurance coverage could significantly improve the sexual health outcomes for this population.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"11"},"PeriodicalIF":2.4,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057024/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144034217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current epidemiological status of mosquito-borne arboviruses in Gulf countries: a systematic review and meta-analysis. 海湾国家蚊媒虫媒病毒的流行病学现状:系统回顾和荟萃分析
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2025-05-01 DOI: 10.1186/s40794-025-00247-2
Khalid Hajissa, Mutiat Hammed-Akanmu, Hussain Omar Alfaqih, Ahmad A Alshehri, Mohammed Dauda Goni, Maha Al-Asmakh

Background: Mosquito-borne viral (MBV) infections caused by dengue virus (DENV), Rift Valley fever virus (RVFV), West Nile virus (WNV), and chikungunya virus (CHIKV) pose a significant global public health concern. The aim of this systematic review is to summarise the reported prevalence data for these viruses in Gulf countries.

Methods: A web search in four electronic databases (Scopus, PubMed, Google Scholar, and Web of Science) was conducted, and forty-four eligible studies were fulfilled the selection criteria and were therefore included in this study. The Pooled prevalence of MBVs was estimated using a random-effects model. The heterogeneity was assessed using Cochrane Q test and I2 test, while publication bias was evaluated using Egger's test.

Results: Using meta-analysis of proportions, the pooled prevalence of MBVs in Gulf countries among 34,367 human and 19,062 Animal samples was estimated to be 22.5% (95% CI: 13.7-31.4) and 11.6% (95% CI: 0.5 - 22.7%), respectively. In human, DENV was the most predominant virus reported in 19 studies, with an overall pooled prevalence of 32.4%, followed by RVFV in 9 studies, with an infection rate of 10.1%, while WNV and CHIKV were only reported in two studies, with overall prevalence rates of 6.4% and 2.4%, respectively. On the other hand, the overall prevalence of WNV and RVFV in animals was estimated to be 27.7% and 1.5%, respectively.

Conclusion: This review revealed that MBVs are highly prevalent among humans in Gulf countries but relatively low in animals. As a result, additional therapeutic and preventive measures are required. However, the study highlights the need for further studies and surveillance to precisely monitor the burden of these viruses in the region.

背景:由登革热病毒(DENV)、裂谷热病毒(RVFV)、西尼罗河病毒(WNV)和基孔肯雅病毒(CHIKV)引起的蚊媒病毒(MBV)感染是一个重大的全球公共卫生问题。本系统综述的目的是总结海湾国家报告的这些病毒流行率数据。方法:检索4个电子数据库(Scopus、PubMed、b谷歌Scholar和web of Science),筛选出44篇符合选择标准的研究纳入本研究。使用随机效应模型估计mbv的总患病率。异质性评价采用Cochrane Q检验和I2检验,发表偏倚评价采用Egger检验。结果:通过比例荟荟性分析,海湾国家34,367例人类和19,062例动物样本中mbv的总患病率估计分别为22.5% (95% CI: 13.7-31.4)和11.6% (95% CI: 0.5 - 22.7%)。在人类中,19项研究报告的DENV是最主要的病毒,总流行率为32.4%,其次是9项研究报告的RVFV,感染率为10.1%,而西尼罗河病毒和CHIKV仅在两项研究中报告,总流行率分别为6.4%和2.4%。另一方面,动物中西尼罗河病毒和裂谷热病毒的总体流行率估计分别为27.7%和1.5%。结论:本综述揭示了mbv在海湾国家的人类中高度流行,而在动物中相对较低。因此,需要采取额外的治疗和预防措施。然而,该研究强调需要进一步的研究和监测,以精确监测该地区这些病毒的负担。
{"title":"Current epidemiological status of mosquito-borne arboviruses in Gulf countries: a systematic review and meta-analysis.","authors":"Khalid Hajissa, Mutiat Hammed-Akanmu, Hussain Omar Alfaqih, Ahmad A Alshehri, Mohammed Dauda Goni, Maha Al-Asmakh","doi":"10.1186/s40794-025-00247-2","DOIUrl":"https://doi.org/10.1186/s40794-025-00247-2","url":null,"abstract":"<p><strong>Background: </strong>Mosquito-borne viral (MBV) infections caused by dengue virus (DENV), Rift Valley fever virus (RVFV), West Nile virus (WNV), and chikungunya virus (CHIKV) pose a significant global public health concern. The aim of this systematic review is to summarise the reported prevalence data for these viruses in Gulf countries.</p><p><strong>Methods: </strong>A web search in four electronic databases (Scopus, PubMed, Google Scholar, and Web of Science) was conducted, and forty-four eligible studies were fulfilled the selection criteria and were therefore included in this study. The Pooled prevalence of MBVs was estimated using a random-effects model. The heterogeneity was assessed using Cochrane Q test and I<sup>2</sup> test, while publication bias was evaluated using Egger's test.</p><p><strong>Results: </strong>Using meta-analysis of proportions, the pooled prevalence of MBVs in Gulf countries among 34,367 human and 19,062 Animal samples was estimated to be 22.5% (95% CI: 13.7-31.4) and 11.6% (95% CI: 0.5 - 22.7%), respectively. In human, DENV was the most predominant virus reported in 19 studies, with an overall pooled prevalence of 32.4%, followed by RVFV in 9 studies, with an infection rate of 10.1%, while WNV and CHIKV were only reported in two studies, with overall prevalence rates of 6.4% and 2.4%, respectively. On the other hand, the overall prevalence of WNV and RVFV in animals was estimated to be 27.7% and 1.5%, respectively.</p><p><strong>Conclusion: </strong>This review revealed that MBVs are highly prevalent among humans in Gulf countries but relatively low in animals. As a result, additional therapeutic and preventive measures are required. However, the study highlights the need for further studies and surveillance to precisely monitor the burden of these viruses in the region.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"13"},"PeriodicalIF":2.4,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12044787/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144043654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychiatric treatment outcomes of travelers admitted to a psychiatric hospital: a retrospective analysis. 入住精神病院的旅行者的精神治疗结果:回顾性分析。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2025-04-30 DOI: 10.1186/s40794-024-00244-x
Achim Burrer, Tobias R Spiller, Jose Marie Koussemou, Georgios Schoretsanitis, Philipp Homan, Steffi Weidt, Erich Seifritz, Stefan Vetter, Stephan T Egger

Background: Travel-related psychiatric disorders range from anxiety disorders to mood disorders, substance abuse, and psychosis. Various travel-associated factors such as dehydration, time shifts, changes in social structures or stress factors are discussed for these disorders. There is a lack of knowledge concerning the quality and outcome of psychiatric treatment in travelers hospitalized abroad. This study is the first to compare outcome of treatment in psychiatric travelers to domestic patients.

Methods: We analyzed electronic health records of travelers in the Psychiatric University Hospital Zurich from January 2013 to December 2020. Each traveler was matched with one Swiss national and one migrant using propensity score matching.

Results: Travelers showed inferior CGI-I scores at discharge (F(2,969) = 5.72; p = 0.003). The length of stay was shorter (F(2,969) = 38.74:p < 0.001) for travelers (9.69 ± 14.31) than for Swiss nationals (24.69 ± 29.42) and migrants (24.74 ± 28.62). The transfer rate to another hospital was higher (X2(2,972) = 50.85: p < 0.001) for travelers (79, 29.4%) than for Swiss nationals (25, 7.7%) or migrants (26, 8.0%).

Conclusions: Psychiatric treatments of hospitalized travelers showed a lower symptom improvement while presenting a more severe overall condition at discharge. Length of stay was shorter compared to domestic patients. Admission of travelers was initiated involuntarily more frequently. This most closely reflects the theory that travelers are typically hospitalized in severe emergencies and are promptly discharged or repatriated after an initial treatment response has been achieved.

背景:与旅行相关的精神疾病包括焦虑症、情绪障碍、药物滥用和精神病。各种旅行相关的因素,如脱水,时间变化,社会结构的变化或压力因素讨论了这些障碍。对于在国外住院的旅行者的精神治疗的质量和结果缺乏了解。本研究是第一个比较精神病旅行者与国内患者治疗结果的研究。方法:分析2013年1月至2020年12月苏黎世精神病学大学医院出行者的电子健康记录。每个旅行者与一个瑞士国民和一个移民使用倾向得分匹配。结果:出行者出院时CGI-I评分较低(F(2,969) = 5.72;p = 0.003)。住院时间较短(F(2,969) = 38.74; p (2,972) = 50.85: p)结论:住院旅行者的精神病学治疗症状改善程度较低,出院时整体病情较严重。住院时间较国内患者短。旅行者的接纳更频繁地不由自主地开始。这最密切地反映了这样一种理论,即旅行者通常在严重紧急情况下住院,并在取得初步治疗反应后迅速出院或遣返。
{"title":"Psychiatric treatment outcomes of travelers admitted to a psychiatric hospital: a retrospective analysis.","authors":"Achim Burrer, Tobias R Spiller, Jose Marie Koussemou, Georgios Schoretsanitis, Philipp Homan, Steffi Weidt, Erich Seifritz, Stefan Vetter, Stephan T Egger","doi":"10.1186/s40794-024-00244-x","DOIUrl":"https://doi.org/10.1186/s40794-024-00244-x","url":null,"abstract":"<p><strong>Background: </strong>Travel-related psychiatric disorders range from anxiety disorders to mood disorders, substance abuse, and psychosis. Various travel-associated factors such as dehydration, time shifts, changes in social structures or stress factors are discussed for these disorders. There is a lack of knowledge concerning the quality and outcome of psychiatric treatment in travelers hospitalized abroad. This study is the first to compare outcome of treatment in psychiatric travelers to domestic patients.</p><p><strong>Methods: </strong>We analyzed electronic health records of travelers in the Psychiatric University Hospital Zurich from January 2013 to December 2020. Each traveler was matched with one Swiss national and one migrant using propensity score matching.</p><p><strong>Results: </strong>Travelers showed inferior CGI-I scores at discharge (F(2,969) = 5.72; p = 0.003). The length of stay was shorter (F(2,969) = 38.74:p < 0.001) for travelers (9.69 ± 14.31) than for Swiss nationals (24.69 ± 29.42) and migrants (24.74 ± 28.62). The transfer rate to another hospital was higher (X<sup>2</sup>(2,972) = 50.85: p < 0.001) for travelers (79, 29.4%) than for Swiss nationals (25, 7.7%) or migrants (26, 8.0%).</p><p><strong>Conclusions: </strong>Psychiatric treatments of hospitalized travelers showed a lower symptom improvement while presenting a more severe overall condition at discharge. Length of stay was shorter compared to domestic patients. Admission of travelers was initiated involuntarily more frequently. This most closely reflects the theory that travelers are typically hospitalized in severe emergencies and are promptly discharged or repatriated after an initial treatment response has been achieved.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"9"},"PeriodicalIF":2.4,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042500/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143996936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evidence of pathogens associated with travelers' diarrhea in Thailand: a systematic review. 与泰国旅行者腹泻相关的病原体证据:系统综述。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2025-04-28 DOI: 10.1186/s40794-024-00243-y
Wanida Mala, Kwuntida Uthaisar Kotepui, Frederick Ramirez Masangkay, Kinley Wangdi, Polrat Wilairatana, Manas Kotepui

Background: Thailand, a major tourist destination, exhibits variations in sanitation and food safety practices that can lead to cases of travelers' diarrhea (TD) caused by a plethora of pathogens. This systematic review synthesizes data on the pathogens associated with TD in Thailand, providing valuable insights into pathogen diversity and distribution, traveler profiles, and geographical regions of concern.

Methods: This systematic review followed the PRISMA guidelines and was registered in PROSPERO (CRD42022346014). A comprehensive search was conducted across PubMed, Embase, Scopus, MEDLINE, and Journals@Ovid databases. The search included terms related to "diarrhea," "travelers," and "Thailand," without restrictions on publication date. Eligible studies focused on travelers to Thailand who developed diarrhea with identified specific pathogens. Data was extracted and synthesized using a narrative approach. The risk of bias was assessed using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist.

Results: A total of 15 studies met the eligibility criteria, identifying that pathogens related to TD in Thailand were bacteria, particularly enterotoxigenic Escherichia coli (ETEC) (80%), followed by Campylobacter jejuni (33.3%) and Salmonella spp. (40%). Viral pathogens such as rotavirus and norovirus were also notable, with Giardia spp. being the most identified parasite. Pathogen distribution varied across different regions of Thailand, with tourism hubs such as Bangkok, Chiang Mai, Phuket, and Krabi reporting a broader range of infections.

Conclusions: This systematic review highlights the diverse range of pathogens associated with TD in Thailand, with bacterial pathogens, specifically ETEC, being the predominant cause in most studies. The findings underscore the importance of preventive measures, such as improved hygiene practices and food safety awareness, especially in high-risk tourist areas. Further research is needed to understand better the risk factors contributing to TD and to develop targeted interventions for prevention.

背景:泰国是一个主要的旅游目的地,在卫生和食品安全实践方面存在差异,这可能导致由过多病原体引起的旅行者腹泻病例。本系统综述综合了与泰国TD相关的病原体数据,为病原体多样性和分布、旅行者概况和值得关注的地理区域提供了有价值的见解。方法:本系统评价遵循PRISMA指南,在PROSPERO注册(CRD42022346014)。在PubMed、Embase、Scopus、MEDLINE和Journals@Ovid数据库中进行了全面的搜索。搜索包括与“腹泻”、“旅行者”和“泰国”相关的词条,没有发布日期的限制。符合条件的研究集中于前往泰国的旅行者,他们患有腹泻,并确定了特定的病原体。数据提取和综合使用叙述的方法。使用乔安娜布里格斯研究所(JBI)关键评估清单评估偏倚风险。结果:共有15项研究符合入选标准,确定泰国与TD相关的病原体为细菌,以产肠毒素大肠杆菌(ETEC)居多(80%),其次为空肠弯曲杆菌(33.3%)和沙门氏菌(40%)。轮状病毒和诺如病毒等病毒病原体也值得注意,其中贾第鞭毛虫是鉴定最多的寄生虫。泰国不同地区的病原体分布各不相同,曼谷、清迈、普吉岛和甲米等旅游中心报告的感染范围更广。结论:本系统综述强调了泰国与TD相关的病原体的多样性,在大多数研究中,细菌性病原体,特别是ETEC是主要原因。研究结果强调了预防措施的重要性,例如改善卫生习惯和食品安全意识,特别是在高风险旅游区。需要进一步研究,以更好地了解导致TD的风险因素,并制定有针对性的预防干预措施。
{"title":"Evidence of pathogens associated with travelers' diarrhea in Thailand: a systematic review.","authors":"Wanida Mala, Kwuntida Uthaisar Kotepui, Frederick Ramirez Masangkay, Kinley Wangdi, Polrat Wilairatana, Manas Kotepui","doi":"10.1186/s40794-024-00243-y","DOIUrl":"https://doi.org/10.1186/s40794-024-00243-y","url":null,"abstract":"<p><strong>Background: </strong>Thailand, a major tourist destination, exhibits variations in sanitation and food safety practices that can lead to cases of travelers' diarrhea (TD) caused by a plethora of pathogens. This systematic review synthesizes data on the pathogens associated with TD in Thailand, providing valuable insights into pathogen diversity and distribution, traveler profiles, and geographical regions of concern.</p><p><strong>Methods: </strong>This systematic review followed the PRISMA guidelines and was registered in PROSPERO (CRD42022346014). A comprehensive search was conducted across PubMed, Embase, Scopus, MEDLINE, and Journals@Ovid databases. The search included terms related to \"diarrhea,\" \"travelers,\" and \"Thailand,\" without restrictions on publication date. Eligible studies focused on travelers to Thailand who developed diarrhea with identified specific pathogens. Data was extracted and synthesized using a narrative approach. The risk of bias was assessed using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist.</p><p><strong>Results: </strong>A total of 15 studies met the eligibility criteria, identifying that pathogens related to TD in Thailand were bacteria, particularly enterotoxigenic Escherichia coli (ETEC) (80%), followed by Campylobacter jejuni (33.3%) and Salmonella spp. (40%). Viral pathogens such as rotavirus and norovirus were also notable, with Giardia spp. being the most identified parasite. Pathogen distribution varied across different regions of Thailand, with tourism hubs such as Bangkok, Chiang Mai, Phuket, and Krabi reporting a broader range of infections.</p><p><strong>Conclusions: </strong>This systematic review highlights the diverse range of pathogens associated with TD in Thailand, with bacterial pathogens, specifically ETEC, being the predominant cause in most studies. The findings underscore the importance of preventive measures, such as improved hygiene practices and food safety awareness, especially in high-risk tourist areas. Further research is needed to understand better the risk factors contributing to TD and to develop targeted interventions for prevention.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"8"},"PeriodicalIF":2.4,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12036122/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144049998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Tropical Diseases, Travel Medicine and Vaccines
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1